As such, a reduction in bioactive NO due to decreased eNOS activity, eNOS uncoupling, and/or a decline in eNOS protein levels is associated with endothelial dysfunction, hypertension, atherosclerosis, coronary artery disease, and heart failure (37, 47). This evidence concerns the gene NOS3 and heart failure.